Consortium of Independent Review Boards
Consortium of Independent Review Boards Consortium of Independent Review Boards Consortium of Independent Review Boards
CIRB ~ IRB RESOURCES
non-profit, organization

ethical review
clinical research independent institutional review boards
Resources: background information about Institutional Review Boards
Materials regarding independent review boards, the role of central institutional review boards and centralized IRB review

Welcome to the Resources Page of the CIRB website.

Set forth below are materials regarding independent review boards, the role of central institutional review boards and centralized IRB review.

In 1998, the Office of the Inspector General of the Department of Health and Human Services published a series of reports regarding institutional review boards, including independent review boards. Two reports from the series are set forth below:

IRBs - A Time For Reform NOTE: PDF file size  5.0MB - REQUIRES: Adobe Reader to view or print
The Emergence of Independent Boards NOTE: PDF file size  0.8MB - REQUIRES: Adobe Reader to view or print



In 2000, OIG issued two reports regarding the recruitment of research participants.

Recruiting Human Subjects - Pressures in Industry-Sponsored Clinical Research NOTE: PDF file size  4.5MB - REQUIRES: Adobe Reader to view or print
Recruiting Human Subjects - Sample Guidelines for Practices NOTE: PDF file size  1.0MB - REQUIRES: Adobe Reader to view or print



In 2000, the following white paper on "The History, Function, and Future of Independent Institutional Review Boards" was submitted to the National Bioethics Advisory Committee.

History - Independent IRBs NOTE: PDF file size 1.5MB - REQUIRES: Adobe Reader to view or print



The DHHS Office of Human Research Protection published a paper summarizing a variety of models for IRB review discussed at a November 2005 workshop. The report is set forth below:

Alt Models of IRB Review NOTE: PDF file size  336KB - REQUIRES: Adobe Reader to view or print



In March 2006, the Food and Drug Administration published guidance describing the parameters for appropriate use of centralized IRB review.

Centralized IRB Review Process in Multicenter Clinical Trials



CIRB has submitted public comments on a variety of proposed regulatory measures, including adverse event reporting and the use of a centralized IRB process. These comments are posted below:

Competing Interests - Submission to PLoS Medicine (Sept. 2006) NOTE: PDF file size  81KB - REQUIRES: Adobe Reader to view or print

Comments on OHRP Draft Guidance on Reporting and Reviewing Adverse Events (January 2006) NOTE: PDF file size  488KB - REQUIRES: Adobe Reader to view or print

Comments on FDA's Draft Guidance for Industry on Using a Centralized IRB Process in Multicenter Clinical Trials (May 2005) NOTE: PDF file size  125KB - REQUIRES: Adobe Reader to view or print

Comments on FDA's Request for General Information: Reporting of Adverse Events to IRBs (April 2005) NOTE: PDF file size  457KB - REQUIRES: Adobe Reader to view or print

CIRB Statement at FDA Public Hearing on Reporting of Adverse Events to IRBs (March 2005) NOTE: PDF file size  153KB - REQUIRES: Adobe Reader to view or print

Comments on FDA Proposed Rule: IRB Registration Requirements (October 2004) NOTE: PDF file size  279KB - REQUIRES: Adobe Reader to view or print

Comments on OHRP Proposed Amendments to the Categories of Research that may be Reviewed by an IRB Through Expedited Review (Dec. 2007) NOTE: PDF file size  153KB - REQUIRES: Adobe Reader to view or print

Comments on OHRP Request for Information on Research Involving Adults with Impaired Decision-Making Capacity (Jan. 2008) NOTE: PDF file size  279KB - REQUIRES: Adobe Reader to view or print



(Please Note: The freely available Adobe Acrobat Reader is required to view & print PDF files.)
Click here to get your free copy of Adobe Reader Version 7
human research participants
CIRB, IRB